CGTX · Cognition Therapeutics Inc
Market Cap
$97.95M
Shares
95.09M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-24 | — | |
| 8-K | 2026-06-18 | 2026-06-17 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-06-04 | — | |
| 8-K | 2026-05-21 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-27 | 2026-06-17 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-02 | — | |
| 8-K | 2026-01-27 | — | |
| 8-K | 2025-12-18 | 2025-12-16 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-09-15 | — | |
| 8-K | 2025-08-28 | 2025-08-27 | |
| 8-K | 2025-08-26 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-20 | 2025-06-18 | |
| 8-K | 2025-06-03 | — | |
| 8-K | 2025-06-02 | — | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-05-07 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | 2025-06-18 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-03-12 | — | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-01-28 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-18 | — | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-10-01 | — | |
| 8-K | 2024-09-13 | 2024-09-12 | |
| 8-K | 2024-08-28 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-29 | — | |
| 8-K | 2024-06-07 | — | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-07 | |
| 10-K | 2024-03-26 | 2023-12-31 | |
| 8-K | 2024-03-26 | — |
Showing 1–50 of 97 filings
Key facts
CIK
1455365
CUSIP
19243B102
13F (30d)
47 filings
47 filers
Visit website
Investor relations